Kiki Wolfkill, art director, producer, and veteran of the Halo franchise and other big Xbox properties, revealed she's left ...

By letting people make choices and experience the outcomes of those choices, gaming provides a much more hands-on way of ...

Jessica has written for online outlets since 2008, and she joined Engadget in 2015 after four years as senior reporter at ...

The long-running Unity vs Unreal Engine debate is intensifying in 2026 as AI integration, pricing models, and hardware demands reshape the game development landscape. Unity remains dominant in mobile ...

Microsoft's former gaming and Xbox VP Ed Fries believes AI is "the big question mark" for gaming moving forward, and says it's not going away.

Research published in The Journal of Clinical Psychiatry characterizes patient-reported improvement with INGREZZA® (valbenazine) capsules across the KINECT® clinical ...

Neurocrine Biosciences, Inc.  today announced the publication of new peer-reviewed research in The Journal of Clinical Psychiatry demonstrating how the Tardive Dyskinesia Impact Scale helps ...

Julia Liuson, president of Microsoft's developer division and a 34-year company veteran, is retiring in June, she told employees in a memo. When GitHub head Thomas Dohmke left last year, three top ...

There’s an old saw in management: What you measure matters. And, typically, you get more of whatever you’re measuring. Software engineers have debated productivity metrics for decades, starting with ...

Veteran Microsoft executive Julia Liuson is leaving after 34 years. Veteran Microsoft executive Julia Liuson is leaving after 34 years. is a senior correspondent and author of Notepad, who has been ...

Ninety-nine is suddenly the magic number for New York City apartment developers. A city government program enacted in 2024 offers a tax exemption to developers of most apartment buildings that have ...

Neurocrine Biosciences, Inc.  today announced the presentation of new real-world evidence demonstrating that adult patients with tardive dyskinesia receiving INGREZZA® (valbenazine) capsules showed ...